Benzinga | Aug 10, 2020 04:13PM EDT

Integra Lifesciences Q2 EPS $0.33 Beats $0.10 Estimate, Sales $258.67M Beat $242.80M Estimate

Integra Lifesciences (NASDAQ:IART) reported quarterly earnings of $0.33 per share which beat the analyst consensus estimate of $0.10 by 230 percent. This is a 54.79 percent decrease over earnings of $0.73 per share from the same period last year. The company reported quarterly sales of $258.67 million which beat the analyst consensus estimate of $242.80 million by 6.53 percent. This is a 32.58 percent decrease over sales of $383.64 million the same period last year.